Aditxt, Inc. Legal Fees
Aditxt, Inc. (ADTX) had Legal Fees of $500.00 thousand as of 2026-02-03, per its 10-Q filed 2026-05-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2026-05-20
- 2026-02-03: Legal Fees $500.00K.
- 2023-07-03: Legal Fees 0 month $10.75K.
- 2023-05-30: Legal Fees 1 month $100.00K.
- 2023-04-24: Legal Fees 1 month $60.00K.
| Period end | Legal Fees | Legal Fees 0 month | Legal Fees 1 month |
|---|---|---|---|
| 2026-02-03 | $500.00K 10-Q · filed 2026-05-20 | ||
| 2023-07-03 | $10.75K 10-K · filed 2024-04-16 | ||
| 2023-05-30 | $100.00K 10-Q · filed 2023-08-14 | ||
| 2023-04-24 | $60.00K 10-Q · filed 2023-08-14 | ||
| 2023-04-04 | $60.00K 10-Q · filed 2023-08-14 | ||
| 2023-02-21 | $75.00K 10-Q · filed 2023-08-14 | ||
| 2022-08-31 | $20.00K 10-K · filed 2023-04-17 | ||
| 2022-05-27 | $16.50K 10-K · filed 2023-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |